1000PEfficacy and safety of oral poly (ADP-ribose) polymerase inhibitor fluzoparib in patients with BRCA1/2 mutations and platinum sensitive recurrent ovarian cancerN Li, L Wu, Y Zhang,J Liu,Q Zhou,J Zhu, R Yin,L Wang,G Li,X Wu, H Pan,S Yao,Q Wu, K Gu,H Zhang, X Wan, R An,J Zou, Q WangANNALS OF ONCOLOGY（2019）引用 1|浏览94暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
